ABT Abbott Laboratories Stock Quote

ABT [NYSE]

Index	S&P 500	P/E	47.63	EPS (ttm)	2.52	Insider Own	0.30%	Shs Outstand	1.78B	Perf Week	-2.65%
Market Cap	215.38B	Forward P/E	22.24	EPS next Y	5.39	Insider Trans	-6.90%	Shs Float	1.76B	Perf Month	4.80%
Income	4.50B	PEG	3.03	EPS next Q	1.28	Inst Own	75.60%	Short Float	0.60%	Perf Quarter	11.31%
Sales	34.61B	P/S	6.22	EPS this Y	24.50%	Inst Trans	-0.04%	Short Ratio	2.12	Perf Half Y	16.08%
Book/sh	18.46	P/B	6.49	EPS next Y	6.51%	ROA	6.50%	Target Price	134.88	Perf Year	51.26%
Cash/sh	3.98	P/C	30.13	EPS next 5Y	15.74%	ROE	14.40%	52W Range	61.61 - 128.54	Perf YTD	9.40%
Dividend	1.80	P/FCF	68.07	EPS past 5Y	7.80%	ROI	9.70%	52W High	-6.81%	Beta	0.72
Dividend %	1.50%	Quick Ratio	1.30	Sales past 5Y	11.10%	Gross Margin	56.80%	52W Low	94.42%	ATR	2.65
Employees	109000	Current Ratio	1.70	Sales Q/Q	28.70%	Oper. Margin	15.80%	RSI (14)	47.07	Volatility	2.05% 2.20%
Optionable	Yes	Debt/Eq	0.57	EPS Q/Q	108.80%	Profit Margin	13.00%	Rel Volume	1.03	Prev Close	121.58
Shortable	Yes	LT Debt/Eq	0.57	Earnings	Jan 27 BMO	Payout	56.80%	Avg Volume	4.96M	Price	119.78
Recom	1.80	SMA20	-3.08%	SMA50	3.65%	SMA200	14.11%	Volume	5,197,681	Change	-1.48%

Jan-28-21

Upgrade

BTIG Research

Neutral → Buy

$140

Sep-11-20

Initiated

Wolfe Research

Outperform

$124

Jun-01-20

Downgrade

Goldman

Neutral → Sell

$84

Mar-05-20

Initiated

Citigroup

Buy

$96

Feb-13-20

Initiated

Goldman

Neutral

$96

Feb-06-20

Resumed

BTIG Research

Neutral

Jan-02-20

Downgrade

Guggenheim

Buy → Neutral

Jun-13-19

Reiterated

BofA/Merrill

Buy

$81 → $90

Feb-07-19

Reiterated

BofA/Merrill

Buy

$73 → $81

Jan-02-19

Downgrade

Citigroup

Neutral → Sell

Nov-30-18

Upgrade

Goldman

Neutral → Buy

Oct-16-18

Initiated

Barclays

Overweight

$80

Jun-27-18

Initiated

Bernstein

Outperform

$73

Jan-30-18

Reiterated

Citigroup

Neutral

$59 → $64

Jan-25-18

Upgrade

William Blair

Mkt Perform → Outperform

Jan-25-18

Reiterated

Stifel

Buy

$63 → $71

Jan-03-18

Initiated

Evercore ISI

Outperform

Jan-02-18

Upgrade

Morgan Stanley

Equal-Weight → Overweight

Jan-02-18

Upgrade

JP Morgan

Neutral → Overweight

Oct-19-17

Reiterated

Stifel

Buy

$58 → $63

Mar-01-21 06:25AM	February Ends in Green Amid Extreme Volatility: 5 Top Picks Zacks
Feb-28-21 06:22AM	3 Great Stocks for Low-Risk Investors Motley Fool
Feb-26-21 11:30AM	Why Is Abbott (ABT) Up 1% Since Last Earnings Report? Zacks
10:16AM	Teleflex (TFX) Beats on Q4 Earnings and Revenues, Margins Fall Zacks
09:26AM	Glaukos (GKOS) Q4 Earnings and Revenues Surpass Estimates Zacks
09:22AM	LHC Group (LHCG) Q4 Earnings Beat Estimates, Revenues Miss Zacks
09:01AM	Allscripts (MDRX) Q4 Earnings and Revenues Beat Estimates Zacks
08:53AM	NuVasive's (NUVA) Q4 Earnings Top Estimates, Margin Declines Zacks
Feb-25-21 05:45PM	Abbott (ABT) Stock Moves -0.65%: What You Should Know Zacks
Feb-24-21 09:31AM	Top 15 Pharmaceutical Companies With Highest R&D Spending Insider Monkey
Feb-23-21 04:20PM	This Medical Stock Just Retook Its Buy Point On Its Unexpected Earnings Beat Investor's Business Daily
09:40AM	This Medical Stock Just Retook Its Buy Point On Unexpected Earnings Beat Investor's Business Daily
Feb-19-21 02:47PM	Sherwin-Williams: Strong Business, Premium Valuation GuruFocus.com
01:25PM	Abbott Declares 389th Consecutive Quarterly Dividend PR Newswire
Feb-18-21 07:15AM	J&J Seeks FDA Authorization For Covid Vaccine; Is JNJ Stock A Buy Now? Investor's Business Daily
Feb-17-21 12:35PM	Domino's Raises $13M For St. Jude Children's Research Hospital: What's Next? Benzinga
Feb-16-21 04:09PM	Abbott Laboratories: The Definition of a Premium Company GuruFocus.com
Feb-12-21 11:47AM	DaVita (DVA) Q4 Earnings and Revenues Fall Shy of Estimates Zacks
10:38AM	DexCom (DXCM) Q4 Earnings Match Estimates, Revenues Beat Zacks
10:05AM	Zimmer (ZBH) Non-Core Arm Spinoff to Aid Amid COVID-19 Crisis Zacks
09:19AM	Bio-Rad (BIO) Q4 Earnings Surpass Estimates, Margins Rise Zacks
09:17AM	Illumina (ILMN) Q4 Earnings Top Estimates, Margins Decline Zacks
08:58AM	Orthofix (OFIX) Launches Limb Lengthening System in US & UK Zacks
08:30AM	This Covid Testing Stock Is Cheap. Why Its Time to Buy. Barrons.com
06:40AM	3 Top Healthcare Stocks to Buy in February Motley Fool
Feb-11-21 08:49PM	This Covid Testing Stock Is Cheap. Why Its Time to Buy Barrons.com
12:24PM	Pacific Biosciences (PACB) Q4 Earnings and Revenues Miss Estimates Zacks
11:47AM	Why You Should Retain Abiomed (ABMD) Stock in Your Portfolio Zacks
10:35AM	LabCorp (LH) Q4 Earnings Beat Estimates, Margins Expand Zacks
09:11AM	Cerner (CERN) Q4 Earnings Match Estimates, Revenues Beat Zacks
08:50AM	HEXO Soars: Stock Adds 7.9% in Session Zacks
07:47AM	Forget Moderna! This Is a More Lucrative Coronavirus Stock Motley Fool
06:55AM	4 Top COVID Stocks to Buy in February Motley Fool
Feb-10-21 12:00PM	Here's Why Abbott (ABT) is a Great Momentum Stock to Buy Zacks
11:31AM	Surmodics (SRDX) Q1 Earnings Beat Estimates, Revenues Miss Zacks
10:18AM	QIAGEN (QGEN) Q4 Earnings Beat Estimates, Margins Improve Zacks
10:14AM	Abbott's Fast, Reliable and Convenient COVID-19 Tests Ramp Up Indonesia's Testing Capability PR Newswire
Feb-09-21 09:59AM	Luminex (LMNX) Q4 Earnings Miss Estimates, Revenues Beat Zacks
09:56AM	Cardiovascular System's (CSII) OAS Cures 1st Patient in Europe Zacks
09:41AM	Boston Scientific (BSX) Hurt by Product Recall, Conversion Zacks
06:50AM	This Stock Could Be a Surprise Growth Pick Motley Fool
Feb-08-21 01:21PM	Heres Why Polen Capital Likes Abbott Laboratories (ABT) Stock Insider Monkey
09:14AM	Hill-Rom's (HRC) Q1 Earnings Beat Estimates, Margins Up Zacks
Feb-07-21 05:58AM	2 Green Flags for Abbott Labs and 1 Red Flag Motley Fool
Feb-06-21 10:59AM	Is Abbott Labs a Good Stock to Buy Now? Motley Fool
Feb-05-21 11:09AM	Zimmer Biomet (ZBH) Beats on Q4 Earnings, to Rejig Portfolio Zacks
09:50AM	Cardinal Health (CAH) Q2 Earnings & Revenues Top Estimates Zacks
06:01AM	Here's the Best Dividend Aristocrat on the Market Right Now Motley Fool
02:00AM	Dems, Biden to Talk Stimulus; Indias Covax Haul: Virus Update Bloomberg
Feb-04-21 01:34PM	Cardiovascular Systems (CSII) Posts Break-Even Earnings in Q2 Zacks
12:25PM	Becton Dickinson (BDX) Earnings Surpass Estimates in Q1 Zacks
11:30AM	Is Abbott Laboratories (ABT) Outperforming Other Medical Stocks This Year? Zacks
11:25AM	Quest Diagnostics (DGX) Q4 Earnings Top, Base Recovery Slows Zacks
09:30AM	Change Healthcare (CHNG) Q3 Earnings Top Estimates, Up Y/Y Zacks
09:29AM	Baxter (BAX) Q4 Earnings and Revenues Surpass Estimates Zacks
09:22AM	AmerisourceBergen (ABC) Q1 Earnings & Revenues Beat Estimates Zacks
08:07AM	Align Technology (ALGN) Beats on Q4 Earnings, Margins Up Zacks
08:06AM	Phibro (PAHC) Q2 Earnings Surpass Estimates, Margins Up Zacks
07:47AM	Where to Invest $10,000 Right Now Motley Fool
07:30AM	3 Dividend Stocks That Just Hiked Their Payouts by 20% Motley Fool
Feb-03-21 10:42AM	Boston Scientific (BSX) Q4 Earnings Miss, Margins Decline Zacks
10:30AM	STERIS' (STE) Earnings & Revenues Surpass Estimates in Q3 Zacks
09:48AM	PerkinElmer (PKI) Q4 Earnings and Revenues Surpass Estimates Zacks
08:16AM	Haemonetics (HAE) Q3 Earnings Top Estimates, Margin Contracts Zacks
Feb-02-21 01:11PM	IDEXX (IDXX) Earnings Beat Estimates in Q4, Margins Rise Zacks
12:20PM	Why Abbott (ABT) Might be Well Poised for a Surge Zacks
10:10AM	Abbott's (ABT) Nutrition & Diabetes Care Beat COVID-19 Woes Zacks
09:39AM	McKesson (MCK) Earnings and Revenues Beat Estimates in Q3 Zacks
08:35AM	Onmicell (OMCL) Q4 Earnings Beat Estimates, Margin Contracts Zacks
05:50AM	The Zacks Analyst Blog Highlights: Netflix, Bristol-Myers Squibb, Abbott Laboratories, Starbucks and Target Zacks
03:53AM	SpaceX to launch billionaire businessman into space on first ever entirely civilian spaceflight and offers ticket to lucky member of the public The Independent
Feb-01-21 01:05PM	Top Research Reports for Netflix, Bristol-Myers & Abbott Zacks
12:00PM	Abbott (ABT) Moves to Buy: Rationale Behind the Upgrade Zacks
11:34AM	NBA Hall of Famer Ray Allen on managing his son's Type 1 diabetes during COVID-19 Yahoo Finance
08:00AM	Yahoo Finance Presents: NBA Legend Ray Allen Yahoo Finance Video
Jan-31-21 11:01PM	Upgrade: Analysts Just Made A Captivating Increase To Their Abbott Laboratories (NYSE:ABT) Forecasts Simply Wall St.
Jan-30-21 06:35AM	Best Healthcare Stocks to Buy in 2021 TheStreet.com
Jan-29-21 06:52AM	Here's a Quick Technical Update on Abbott Laboratories TheStreet.com
Jan-28-21 11:07PM	Abbott Laboratories (NYSE:ABT) Just Reported Yearly Earnings And Analysts Are Lifting Their Estimates Simply Wall St. +5.34%
11:15AM	Why Abbott Labs Stock Is Jumping Today Motley Fool
08:03AM	The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO Benzinga
06:20AM	Better Buy: Abbott Laboratories vs. Intuitive Surgical Motley Fool
Jan-27-21 04:24PM	Abbott Smashes Quarterly Estimates On Covid Testing Boom Is ABT Stock A Buy? Investor's Business Daily
04:15PM	Abbott Laboratories Stock Loses Buy Point Despite Coronavirus Test Boom Investor's Business Daily
03:00PM	Abbott Laboratories (ABT) Q4 2020 Earnings Call Transcript Motley Fool
03:00PM	Here's How Abbott Labs Hit a Home Run With Its Q4 Results Motley Fool
10:49AM	Durable Goods Orders For December Rose Lower-than-Expected Zacks
10:42AM	Abbott (ABT) Q4 Earnings Top, Diagnostic Test Sales Solid Zacks
09:54AM	P/E Ratio Insights for Abbott Laboratories Benzinga
08:45AM	Abbott (ABT) Beats Q4 Earnings and Revenue Estimates Zacks
08:15AM	Abbott Laboratories: Q4 Earnings Insights Benzinga
08:10AM	Abbott beats sales estimates as rapid diagnostics business now generates one-fourth of revenue MarketWatch
07:30AM	Abbott Reports Fourth-Quarter 2020 Results; Issues Strong Double-Digit Growth Forecast for 2021 PR Newswire
07:21AM	What Does Abbott's Debt Look Like? Benzinga
04:01AM	Abbott Laboratories Beats Earnings on Strong Sales TheStreet.com
Jan-26-21 10:10AM	Earnings Preview: Abbott Laboratories Benzinga
07:45AM	Abbott's Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab PR Newswire
07:16AM	2 Stocks I'll Hold Forever Motley Fool
Jan-22-21 08:29PM	Shipping Costs Are Spiking. What That Means for Inflation. Barrons.com
Jan-20-21 08:22AM	Demand for COVID-19 Tests to Drive Abbott (ABT) Q4 Earnings Zacks

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in North Chicago, Illinois.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kumbier Michelle	Director	Feb 23	Buy	122.50	2,040	249,900	7,296	Feb 25 06:05 PM
Moreland Mary K	EXECUTIVE VICE PRESIDENT	Feb 22	Sale	121.84	400	48,734	75,706	Feb 23 07:05 PM
Moreland Mary K	EXECUTIVE VICE PRESIDENT	Feb 16	Sale	128.49	505	64,887	63,373	Feb 18 05:57 PM
Funck Robert E	EXECUTIVE VICE PRESIDENT	Feb 02	Option Exercise	39.12	31,325	1,225,434	193,542	Feb 04 06:56 PM
MANNING JOSEPH J	SENIOR VICE PRESIDENT	Feb 02	Sale	123.03	3,130	385,084	59,681	Feb 03 07:20 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Feb 01	Option Exercise	38.78	203,393	7,887,902	355,289	Feb 03 07:10 PM
Scoggins Christopher J	SENIOR VICE PRESIDENT	Feb 01	Option Exercise	44.83	45,000	2,017,200	84,706	Feb 03 07:14 PM
MANNING JOSEPH J	SENIOR VICE PRESIDENT	Feb 01	Option Exercise	38.40	18,750	720,000	81,561	Feb 03 07:20 PM
MANNING JOSEPH J	SENIOR VICE PRESIDENT	Feb 01	Sale	122.79	18,750	2,302,264	62,811	Feb 03 07:20 PM
Scoggins Christopher J	SENIOR VICE PRESIDENT	Feb 01	Sale	123.24	45,000	5,545,800	39,706	Feb 03 07:14 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Feb 01	Sale	123.47	203,393	25,113,252	151,896	Feb 03 07:10 PM
NOVAKOVIC PHEBE N	Director	Dec 04	Option Exercise	34.97	14,681	513,431	45,794	Dec 08 05:58 PM
NOVAKOVIC PHEBE N	Director	Dec 04	Sale	107.28	4,790	513,849	41,004	Dec 08 05:58 PM
OSBORN WILLIAM A	Director	Nov 24	Option Exercise	43.64	21,448	935,991	79,745	Nov 25 05:41 PM
Funck Robert E	Executive Vice President & CFO	Oct 26	Option Exercise	38.40	83,333	3,199,987	265,550	Oct 28 06:33 PM
Funck Robert E	Executive Vice President & CFO	Oct 26	Sale	108.83	83,333	9,068,955	182,217	Oct 28 06:33 PM
Wainer Andrea F	Executive Vice President	Sep 30	Option Exercise	38.40	30,000	1,152,000	74,080	Oct 01 05:50 PM
Wainer Andrea F	Executive Vice President	Sep 30	Sale	107.01	30,000	3,210,360	44,080	Oct 01 05:50 PM
Wainer Andrea F	Executive Vice President	Sep 23	Sale	102.47	3,650	374,031	44,080	Sep 25 05:06 PM
WOODGRIFT RANDEL WILLIAM	Senior Vice President	Sep 11	Sale	105.28	2,500	263,200	46,267	Sep 15 06:14 PM
Ginascol John F	Executive Vice President	Sep 01	Option Exercise	43.16	72,098	3,111,584	136,775	Sep 03 06:33 PM
BIRD ROGER	Senior Vice President	Sep 01	Sale	108.73	6,290	683,929	56,630	Sep 03 05:52 PM
CAPEK JOHN M	Executive Vice President	Aug 27	Option Exercise	27.03	52,300	1,413,857	369,100	Aug 31 06:27 PM
Salvadori Daniel Gesua Sive	Executive Vice President	Aug 27	Option Exercise	47.00	42,479	1,996,513	144,912	Aug 31 06:28 PM
Salvadori Daniel Gesua Sive	Executive Vice President	Aug 27	Sale	111.86	42,479	4,751,701	102,433	Aug 31 06:28 PM
CAPEK JOHN M	Executive Vice President	Aug 27	Sale	111.86	52,300	5,850,278	316,800	Aug 31 06:27 PM
NOVAKOVIC PHEBE N	Director	Jul 23	Option Exercise	25.05	3,739	93,677	32,046	Jul 27 05:06 PM
NOVAKOVIC PHEBE N	Director	Jul 23	Sale	100.78	933	94,026	31,113	Jul 27 05:06 PM
AUSTIN ROXANNE S	Director	Jul 22	Sale	99.80	6,844	683,038	40,043	Jul 23 05:07 PM
PEDERSON MICHAEL J	Senior Vice President	Jul 21	Option Exercise	0.00	23,008	0	96,899	Jul 23 05:04 PM
PEDERSON MICHAEL J	Senior Vice President	Jul 21	Sale	98.00	23,008	2,254,784	73,891	Jul 23 05:04 PM
Earnhardt Lisa D	Executive Vice President	Jun 10	Sale	90.84	872	79,216	72,074	Jun 12 05:07 PM
LANE ANDREW H	Executive Vice President	May 05	Option Exercise	43.82	80,000	3,505,314	145,822	May 07 05:02 PM
LANE ANDREW H	Executive Vice President	May 05	Sale	92.00	80,000	7,360,104	65,822	May 07 05:02 PM
WOODGRIFT RANDEL WILLIAM	Senior Vice President	Apr 28	Sale	93.18	3,724	347,012	48,767	Apr 30 06:34 PM
Funck Robert E	Executive Vice President & CFO	Apr 21	Option Exercise	36.42	36,700	1,336,638	206,072	Apr 23 09:27 PM
Contreras Jaime	Senior Vice President	Apr 21	Option Exercise	57.12	108,412	6,192,995	145,431	Apr 23 09:26 PM
CAPEK JOHN M	Executive Vice President	Apr 21	Option Exercise	22.39	50,100	1,121,834	366,900	Apr 23 09:34 PM
Ginascol John F	Executive Vice President	Apr 21	Option Exercise	38.40	63,200	2,426,880	129,645	Apr 23 09:41 PM
CAPEK JOHN M	Executive Vice President	Apr 21	Sale	95.87	50,100	4,803,326	316,800	Apr 23 09:34 PM
Scoggins Christopher J	Senior Vice President	Apr 21	Sale	96.10	414	39,785	39,706	Apr 23 09:28 PM
Ginascol John F	Executive Vice President	Apr 21	Sale	96.00	63,200	6,067,051	66,445	Apr 23 09:41 PM
Boudreau Philip P	Vice President	Mar 13	Sale	82.00	10,600	869,200	22,463	Mar 16 06:47 PM
Watkin Jared	Senior Vice President	Mar 06	Sale	82.00	8,248	676,336	68,696	Mar 10 05:06 PM
Funck Robert E	Executive Vice President & CFO	Mar 02	Sale	77.89	1,356	105,619	169,372	Mar 03 05:28 PM
WOODGRIFT RANDEL WILLIAM	Senior Vice President	Mar 02	Sale	77.89	1,420	110,604	53,859	Mar 03 05:27 PM
BIRD ROGER	Senior Vice President	Mar 02	Sale	77.89	666	51,875	62,920	Mar 03 05:23 PM
DALE MICHAEL D	Senior Vice President	Mar 02	Sale	77.89	787	61,299	34,763	Mar 03 05:21 PM
Ginascol John F	Executive Vice President	Mar 02	Sale	77.63	6,606	512,805	66,445	Mar 03 05:20 PM
Contreras Jaime	Senior Vice President	Mar 02	Sale	77.89	2,001	155,858	37,019	Mar 03 05:19 PM
Watkin Jared	Senior Vice President	Mar 02	Sale	77.89	1,761	137,164	76,944	Mar 03 05:19 PM
ALLEN HUBERT L	Executive Vice President	Mar 02	Sale	77.89	1,208	94,091	151,896	Mar 03 05:16 PM
Scoggins Christopher J	Senior Vice President	Mar 02	Sale	77.89	1,240	96,584	41,168	Mar 03 05:15 PM
Salvadori Daniel Gesua Sive	Executive Vice President	Mar 02	Sale	77.89	999	77,812	103,493	Mar 03 05:16 PM
BRYNELSEN CHARLES	Senior Vice President	Mar 02	Sale	77.89	1,781	138,722	45,460	Mar 03 05:13 PM
Wainer Andrea F	Executive Vice President	Mar 02	Sale	77.89	1,429	111,305	49,498	Mar 03 05:10 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience